Articles and Videos
IntegraSyn™ – a flexible, high yield and cost-effective cannabinoid manufacturing system
InMed’s scientific team has developed IntegraSyn™ - a flexible, high yield and cost-effective manufacturing system to produce pharmaceutical-grade, bio-identical cannabinoids. InMed recently announced that IntegraSyn™...
InMed’s CEO Eric A. Adams presents at Edison Open House: Global Healthcare 2021
InMed Pharmaceuticals CEO, Eric A. Adams, is interviewed by Science Journalist and Broadcaster Vivienne Parry Obe at the Edison Open House: Global Healthcare Conference 2021....
Source: Edison TV